- Home
- APLT vs ECC Comparison
APLT vs ECC Comparison
Compare APLT & ECC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- ECC
- Stock Information
- Founded
- APLT 2016
- ECC 2014
- Country
- APLT United States
- ECC United States
- Employees
- APLT N/A
- ECC N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- ECC
- Sector
- APLT Health Care
- ECC
- Exchange
- APLT Nasdaq
- ECC NYSE
- Market Cap
- APLT 44.0M
- ECC N/A
- IPO Year
- APLT 2019
- ECC N/A
- Fundamental
- Price
- APLT $0.41
- ECC $7.55
- Analyst Decision
- APLT Buy
- ECC Buy
- Analyst Count
- APLT 7
- ECC 2
- Target Price
- APLT $6.10
- ECC $9.25
- AVG Volume (30 Days)
- APLT 2.6M
- ECC 1.2M
- Earning Date
- APLT 08-06-2025
- ECC 08-05-2025
- Dividend Yield
- APLT N/A
- ECC 25.26%
- EPS Growth
- APLT N/A
- ECC N/A
- EPS
- APLT N/A
- ECC N/A
- Revenue
- APLT $265,000.00
- ECC $191,298,536.00
- Revenue This Year
- APLT $1,768.13
- ECC $26.00
- Revenue Next Year
- APLT $292.85
- ECC $9.62
- P/E Ratio
- APLT N/A
- ECC N/A
- Revenue Growth
- APLT N/A
- ECC 29.29
- 52 Week Low
- APLT $0.30
- ECC $6.54
- 52 Week High
- APLT $10.62
- ECC $10.11
- Technical
- Relative Strength Index (RSI)
- APLT 58.87
- ECC 40.88
- Support Level
- APLT $0.32
- ECC $7.74
- Resistance Level
- APLT $0.36
- ECC $7.83
- Average True Range (ATR)
- APLT 0.04
- ECC 0.08
- MACD
- APLT 0.01
- ECC 0.01
- Stochastic Oscillator
- APLT 94.92
- ECC 17.50
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.